HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Li Selected Research

CME-Carbodiimide (CMEC)

1/2020Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
1/2017Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Li Research Topics

Disease

446Neoplasms (Cancer)
10/2022 - 09/2002
144Breast Neoplasms (Breast Cancer)
07/2022 - 05/2006
86Inflammation (Inflammations)
10/2022 - 07/2003
85Neoplasm Metastasis (Metastasis)
10/2022 - 12/2007
63Infections
04/2022 - 10/2002
52Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2002
39Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2002
38Carcinogenesis
04/2022 - 01/2006
33Fibrosis (Cirrhosis)
12/2021 - 03/2004
31Wounds and Injuries (Trauma)
01/2022 - 10/2003
30Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2010
29Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 12/2007
29Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2007
28Pain (Aches)
07/2022 - 08/2002
28Reperfusion Injury
03/2022 - 03/2008
27Lung Neoplasms (Lung Cancer)
05/2022 - 09/2007
27Triple Negative Breast Neoplasms
01/2022 - 06/2012
26Atherosclerosis
01/2022 - 11/2008
25Alzheimer Disease (Alzheimer's Disease)
09/2020 - 07/2008
23Leukemia
11/2022 - 12/2010
23Hypoxia (Hypoxemia)
07/2022 - 04/2010
22Insulin Resistance
08/2022 - 01/2004
22Ischemia
01/2022 - 09/2002
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 01/2012
18Liver Neoplasms (Liver Cancer)
07/2022 - 12/2002
18Carcinoma (Carcinomatosis)
01/2022 - 09/2002
18Myocardial Infarction
01/2021 - 06/2007
17Glioma (Gliomas)
01/2022 - 03/2003
17Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2010
17Body Weight (Weight, Body)
09/2021 - 04/2005
16Cognitive Dysfunction
01/2022 - 04/2012
16Obesity
07/2021 - 04/2005
16Non-alcoholic Fatty Liver Disease
02/2021 - 05/2011
14Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 05/2013
14Infarction (Infarctions)
01/2022 - 04/2008
13COVID-19
10/2022 - 01/2020
13Necrosis
07/2022 - 09/2002
13Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 07/2009
13Lymphatic Metastasis
01/2022 - 03/2013
13Adenocarcinoma
01/2022 - 11/2009
13Disease Progression
10/2021 - 01/2010
13Fatigue
07/2021 - 09/2011
13Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2021 - 12/2006
13Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 06/2005
13Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 10/2009

Drug/Important Bio-Agent (IBA)

152Proteins (Proteins, Gene)FDA Link
08/2022 - 09/2002
104Biomarkers (Surrogate Marker)IBA
11/2022 - 07/2002
65Pharmaceutical PreparationsIBA
10/2022 - 03/2005
62MicroRNAs (MicroRNA)IBA
03/2022 - 03/2010
55Biological ProductsIBA
07/2021 - 09/2002
39CytokinesIBA
10/2022 - 04/2010
38DNA (Deoxyribonucleic Acid)IBA
07/2022 - 06/2003
35Messenger RNA (mRNA)IBA
01/2022 - 06/2005
34Therapeutic UsesIBA
10/2022 - 03/2004
34Long Noncoding RNAIBA
06/2022 - 04/2014
32LipidsIBA
10/2022 - 01/2003
32Hormones (Hormone)IBA
06/2022 - 05/2006
30Glucose (Dextrose)FDA LinkGeneric
08/2022 - 09/2003
28Indicators and Reagents (Reagents)IBA
06/2022 - 10/2007
27RNA (Ribonucleic Acid)IBA
01/2022 - 03/2006
27AntigensIBA
01/2022 - 08/2002
26EnzymesIBA
09/2022 - 01/2005
25Insulin (Novolin)FDA Link
08/2022 - 04/2005
25Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 09/2007
23Interleukin-6 (Interleukin 6)IBA
03/2022 - 08/2005
22AntibodiesIBA
05/2022 - 07/2005
22Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2012
21Peptides (Polypeptides)IBA
01/2022 - 01/2005
20Phosphotransferases (Kinase)IBA
02/2022 - 09/2002
18LigandsIBA
01/2022 - 02/2009
18CholesterolIBA
01/2022 - 03/2010
17Small Interfering RNA (siRNA)IBA
01/2022 - 08/2010
17Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 10/2006
17VaccinesIBA
01/2022 - 07/2002
16Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2010
16CateninsIBA
12/2021 - 03/2016
15AnthracyclinesIBA
01/2022 - 01/2010
15Monoclonal AntibodiesIBA
01/2021 - 08/2002
14Estrogen ReceptorsIBA
01/2022 - 01/2011
14Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 08/2005
13Retinaldehyde (Retinal)IBA
04/2022 - 09/2002
13Immune Checkpoint InhibitorsIBA
02/2022 - 01/2018
13Chimeric Antigen ReceptorsIBA
02/2022 - 05/2014
13oxidized low density lipoproteinIBA
01/2022 - 04/2005
13AlbuminsIBA
01/2022 - 05/2007
13Caspase 3 (Caspase-3)IBA
01/2022 - 04/2008
13ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2008
13Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2021 - 09/2009
13human ERBB2 proteinIBA
02/2021 - 12/2011
13Blood Glucose (Blood Sugar)IBA
01/2019 - 11/2008
12ChromatinIBA
11/2022 - 07/2008
12Doxorubicin (Adriamycin)FDA LinkGeneric
09/2022 - 09/2007

Therapy/Procedure

206Therapeutics
11/2022 - 06/2003
75Drug Therapy (Chemotherapy)
06/2022 - 09/2003
38Immunotherapy
08/2022 - 03/2003
26Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2022 - 06/2012
21Transplantation
01/2022 - 05/2007
16Radiotherapy
10/2021 - 02/2007
14Neoadjuvant Therapy
01/2022 - 02/2012
13Adjuvant Chemotherapy
01/2022 - 01/2008